Mar 5, 2025 · Since United and MannKind reported their 4th Q results, United stock has lost $2.15 billion in Market Capitalization. Merck is eating its lunch, dinner, and maybe breakfast." We've spent an enormous amount of time focused on Yutrepia and its possible impacts on market share in the second half of this year.

Feb 8, 2025 · Add that to Afrezza, Tyvaso DPI, and potentially clofazimine (the other pipeline candidate) and MannKind might enjoy $4 EPS resulting in $40 to $50 PPS. I'll take a 10x increase in share price any day. I do not call that "small potatoes". And lest people forget, what I described is the plan outlined by MannKind management more than a year ago.

Feb 6, 2025 · MannKind to Present at Upcoming Investor Conferences DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung …

Feb 22, 2025 · You and castlerockchris both confirmed something I was curious about and posted about some time back which was the tension between getting shares the bond holders were entitled to per the bond agreement but didn't want because they're not buy-and-hold long investors (in MNKD at least) and the pressure of offloading the assets they don't want (MNKD …

Oct 28, 2022 · MNKD Product Script Counts and Other Metrics. Articles. MNKD Resource Center

Feb 2, 2025 · I contemplated writing a long narrative about the undeniable fact that for each of the products MannKind has a stream of revenue, each is considered as being a critical needs product. This simply means that diabetes and PAH drugs must be dosed on at least a daily dosage and in the case of Tyvaso DPI, it has to be dosed every 4 hours.

Feb 4, 2025 · I have made it well known that my investment in this market is Liquidia vs. MannKind. Merely look at today’s share price for each company—and tell me if you have held MannKind since Afrezza was first approved and before their 1for-5 reverse split—and that $5.00 price you see today equates to $1.00 for long-term holders.

Jun 5, 2022 · Message board for discussion of MNKD, MannKind Corporation. MannKind MNKD Message Board. Skip Navigation.

Apr 26, 2021 · Message board for discussion of MNKD, MannKind Corporation. Amendment to MidCap Credit Facility On April 22, 2021, MannKind Corporation (“MannKind”) and MannKind’s wholly owned subsidiaries, MannKind LLC (“MannKind LLC”), and QrumPharma, Inc. (“Qrum,” and collectively with MannKind and MannKind LLC, the “Company”), entered into an …

Jan 22, 2025 · Message board for discussion of MNKD, MannKind Corporation. MannKind MNKD Message Board. Skip Navigation.